Multiple Sclerosis Journal

Titel Veröffentlichungsdatum Sprache Zitate
Actrims Steering Committee1996/12/01English
Marta Elian: Obituary2016/12/12English
Instructions for Authors1996/09/01English
Models of Care in Multiple Sclerosis September 27-29, 1996 Atlanta, Georgia, USA1996/09/01English
Lay Summaries of Papers for Volume 2, Issue 21996/09/01English
Instructions for authors1995/11/01English
Model Systems I1998/05/01English
Minimal and Moderate Impairment1998/05/01English
Physician-assisted death should be available to people with MS – No2017/09/01English
Physician-assisted death should be available to people with MS – YES2017/09/01English
Lay Summaries of Papers for Volume I Issue 51996/04/01English
Multiple Sclerosis Fact Book1996/04/01English
Lay Summaries of Papers for Volume I Issue 31995/11/01English
Reply to letter to the editor: Dimethyl fumarate for patients with neuromyelitis optica spectrum disorder by Pitarokoili and Gold2017/07/27English
Letter to the editor2017/07/27English
MS: Frontiers in Patient Care and Disease Management Platform Presentations1998/05/01English
Model Systems II1998/05/01English
Frontiers in Multiple Sclerosis1998/05/01English
Treating Symptoms1998/05/01English
MS: Frontiers in Science & Joint Sessions Platform Presentations1998/05/01English
Research Meets Care1998/05/01English
Gene Therapy1998/05/01English
Stop inflammation and you stop neurodegeneration in MS – Commentary2017/05/02English
Clinical commentary on “Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumab”2017/06/23English
Clinical commentary on ‘Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder with recurrent short partial transverse myelitis and favorable prognosis: Two new cases’, by Wang et al.2017/06/05English
Editorial2017/06/23English
Much, if not all, of the cortical damage in MS can be attributed to the microglial cell – No2018/05/14English
Much, if not all, of the cortical damage in MS can be attributed to the microglial cell – Commentary2018/05/14English
Clinical commentary on ‘Late-onset neutropenia and neurological relapse during long-term rituximab therapy in MOG antibody spectrum disorder’2018/05/09English
The era of GWAS is over – Commentary2017/12/18English